Share: Facebook Twitter LinkedIn
Activity Provided By:

The France Foundation.

Beyond the Basics of PAH: A Case-based Learning Experience With Real World Challenges and Solutions

Access Activity

Overview / Abstract:

Target Audience
This activity is intended for pulmonologists, primary care providers, and other health care providers who may be involved in the management of patients with PAH.

Program Overview
Pulmonary arterial hypertension is a progressive, irreversible disease that is frequently delayed in diagnosis and treatment. Treatment is critical to reduce risk of progression. Clinicians, however, are ill-prepared to make a rapid diagnosis of PAH and choose optimal therapies to manage these patients. Given the challenges associated with timely diagnosis and treatment of PAH, education for clinicians managing this disease is critical.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Assess patients with varying degrees of symptomatology for PAH
Diagnose PAH in a timely fashion

Expiration

May 26, 2022

Discipline(s)

Physician CME

Format

Online

Credits / Hours

1.0

Accreditation

ACCME

Presenters / Authors / Faculty

Deborah Jo Levine, MD

Sponsors / Supporters / Grant Providers

Actelion Pharmaceuticals US, Inc, a Janssen Pharmaceutical Company of Johnson & Johnson

Keywords / Search Terms

Relias LLC Relias, Free CME, PAH Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map